Browsing Tag
Arensia Exploratory Medicine
1 post
Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
Moleculin Biotech's Annamycin shows 43% leukemia remission, but funding risks persist. See what the pivotal 2027 readout means for MBRX.